HealthInsight
HealthInsight HealthInsight
About HealthInsight
Healthcare Professionals

Quality Improvement Projects - Medicare ►

Community Improvement Projects ►

Beneficiary Protection Program

Healthcare Performance Rankings
Value-Driven Healthcare
HealthInsight Awards
Partnerships
Consumers

HOMEChronic Kidney Disease (CKD)

Chronic Kidney Disease (CKD)

Overview | Resources
Contact Us

NewWatch a news clip about CKD from KLAS in Las Vegas
Watch a news clip about CKD from KUTV

Chronic Kidney Disease affects one in nine Americans

HealthInsight and a statewide network of health care partners are collaborating to take on chronic kidney disease (CKD). Together, we will educate at risk patients and promote timely screening and preventive measures to slow the progression of this rising nationwide healthcare issue. Click here for more of our key messages.
  • Statistics now show that 26 million Americans have CKD and another 20 million are at increased risk.
  • The early stages of CKD often have no outward symptoms, and damage to the kidneys is irreversible.
  • Early screening and education for patients will save lives.
  • African Americans, Hispanics, Pacific Islanders, Native Americans and Seniors are at increased risk.
  • In the state of Nevada, the incidence of CKD is one in every seven adults.
  • In the state of Utah, roughly one in eight adults have CKD.

 

Overview

The two main causes of chronic kidney disease are diabetes and high blood pressure, which are responsible for up to two-thirds of the cases. Having a family history of kidney disease, being older or belonging to a population group that has a high rate of diabetes or high blood pressure places you at increased risk for kidney disease.

HealthInsight, Nevada and Utah, are two of the ten states awarded a Centers for Medicare & Medicaid Services contract to undertake an initiative to address this growing concern with a goal to make statewide gains on the following measures (click here for details):

  1. Timely testing to reduce the rate of kidney failure due to diabetes;
  2. Slowing the progression of this disease in individuals with diabetes through the use of ACE inhibitor and/or an angiotensin receptor blocking (ARB) agent; and
  3. Arteriovenous fistula (AV fistula) placement and maturation (as a first choice for arteriovenous access where medically appropriate) for individuals who elect, as part of timely renal replacement counseling, hemodialysis as their treatment option for kidney failure.

HealthInsight has enlisted the support, expertise knowledge and collaboration of all individuals and agencies with an interest in addressing this health care concern. Please click on the links below for more details and resources.

How will we accomplish our goals?

How will we monitor our progress?

How can you help?

 

Contact Us
Contact us with your questions, your experiences with barriers or successes in this area and/or your interest in joining any of our groups.

In Utah:
David Cook
CKD Project Coordinator
Phone: 801-892-6623
Email: utckd@healthinsight.org

In Nevada:
Donna Thorson
CKD Project Coordinator
Phone: 702-933-7327
Email: nvckd@healthinsight.org

Bottom Footer

Top Of Page

 

 

 

 

 

 

 

 

 

 

 

 

Search Our Site Contact Us Events HealthInsight